Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

65.51
+1.101.71%
Post-market: 65.38-0.1300-0.20%19:30 EDT
Volume:2.20M
Turnover:143.82M
Market Cap:12.66B
PE:172.86
High:65.59
Open:64.41
Low:63.57
Close:64.41
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:1.13
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:2.00
PE(LYR):36.39

Loading ...

Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 09, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 28, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2023

Major Issues Report

8-K - Current report